Brief: Conba Pharmaceutical Signs Strategic Framework Agreement With Consun Pharmaceutical
Jan 7 (Reuters) - Zhejiang Conba Pharmaceutical Co Ltd
600572.SS :
* SAYS IT SIGNS STRATEGIC COOPERATION FRAMEWORK AGREEMENT
WITH
CONSUN PHARMACEUTICAL 1681.HK
Source text http://static.sse.com.cn/disclosure/listedinfo/announcement/c/new/2022-01-08/600572_20220108_1_acsL06RF.pdf
Further company coverage: 600572.SS
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director